Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aldeyra Therapeutics, Inc. (ALDX)  
$3.93 0.01 (0.25%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 57,860,000
Market Cap: 227.39(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.47 - $11.89
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 14.8
Insider 6 Months    : 14.8
Insider 3/6 Months : 29.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Aldeyra Therapeutics is a biotechnology company focused on discovering and developing therapies designed to treat immune-mediated diseases. Co.'s primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. Co. has additional product candidates in development for autoimmune diseases and other immune-mediated disease, as well as for proliferative vitreoretinopathy (PVR) and other retinal diseases. Co. has rights to ADX-2191, a vitreous-compatible methotrexate formulation for intraocular injection, for the prevention of PVR, a retinal disease, and primary vitreoretinal lymphoma, a rare cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 682,265 682,265 682,265 2,150,494
Total Buy Value $2,768,372 $2,768,372 $2,768,372 $11,311,413
Total People Bought 1 1 1 3
Total Buy Transactions 5 5 5 17
Total Shares Sold 250,945 250,945 3,007,444 3,007,444
Total Sell Value $805,803 $805,803 $5,259,111 $5,259,111
Total People Sold 3 3 4 4
Total Sell Transactions 7 7 9 9
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 112
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brady Todd C President and CEO   •       •      –    2014-05-07 4 B $8.00 $100,000 D/D 12,500 15,089 2.81     -
   Joyce Martin Joseph Director   –       •      –    2014-05-07 4 B $8.00 $100,000 D/D 12,500 12,500 2.39     -
   Vitullo Nicole 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 D/D 21,250 1,973,389     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2014-05-01 4 D $8.00 $375,008 I/I (46,876) 1,750,292     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2014-05-01 4 OE $5.16 $375,080 I/I 72,690 1,773,730     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2014-05-01 4 A $0.00 $0 I/I 1,724,478 1,724,478     -
   Vitullo Nicole 10% Owner   –       –       •   2014-05-01 4 A $0.00 $0 D/D 9,208 9,208     -
   Vitullo Nicole 10% Owner   –       –       •   2014-05-01 4 D $8.00 $625,008 D/D (78,126) 1,952,139     -
   Vitullo Nicole 10% Owner   –       –       •   2014-05-01 4 OE $5.16 $625,144 D/D 121,152 1,991,202     -
   Vitullo Nicole 10% Owner   –       –       •   2014-05-01 4 A $0.00 $0 D/D 1,909,113 1,909,113     -
   Kamdar Kim P. 10% Owner   –       –       •   2014-05-01 3 IO $0.00 $0 D/D 0 10,358     -
   Brady Todd C President and CEOOfficer   •       •      –    2014-05-01 3 IO $0.00 $0 D/D 0 2,589     -
  112 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us